Projects per year
Abstract
Transcriptome deconvolution aims to estimate the cellular composition of an RNA sample from its gene expression data, which in turn can be used to correct for composition differences across samples. The human brain is unique in its transcriptomic diversity, and comprises a complex mixture of cell-types, including transcriptionally similar subtypes of neurons. Here, we carry out a comprehensive evaluation of deconvolution methods for human brain transcriptome data, and assess the tissue-specificity of our key observations by comparison with human pancreas and heart. We evaluate eight transcriptome deconvolution approaches and nine cell-type signatures, testing the accuracy of deconvolution using in silico mixtures of single-cell RNA-seq data, RNA mixtures, as well as nearly 2000 human brain samples. Our results identify the main factors that drive deconvolution accuracy for brain data, and highlight the importance of biological factors influencing cell-type signatures, such as brain region and in vitro cell culturing.
Original language | English |
---|---|
Article number | 1358 |
Journal | Nature Communications |
Volume | 13 |
Issue number | 1 |
DOIs | |
Publication status | Published - Dec 2022 |
Fingerprint
Dive into the research topics of 'Comprehensive evaluation of deconvolution methods for human brain gene expression'. Together they form a unique fingerprint.Datasets
-
Comprehensive Evaluation of Human Brain Gene Expression Deconvolution Methods
Sutton, G. J. (Creator), Poppe, D. (Creator), Simmons, R. (Creator), Nawaz, U. (Creator), Lister, R. (Creator), Gagnon-Bartsch, J. A. (Creator) & Voineagu, I. (Creator), Gene Expression Omnibus (NCBI), 28 Aug 2021
DOI: 10.26182/2p1z-rx18, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE175772
Dataset
-
Natural and artificial regulation of the epigenome in pluripotency, cell identity, and development
Lister, R. (Investigator 01)
NHMRC National Health and Medical Research Council
1/01/20 → 31/12/24
Project: Research
-
Investigating the molecular signature of ASD through integrative genomics
Voineagu, I. (Investigator 01), Lister, R. (Investigator 02) & Gratten, J. (Investigator 03)
NHMRC National Health and Medical Research Council
1/01/18 → 31/12/20
Project: Research